Protein Design Labs Incorporated

PDL is a leader in the development of humanized monoclonal antibodies for the prevention and treatment of a variety of disease conditions. PDL currently has antibodies under development for autoimmune and inflammatory conditions, transplantation, cancers and viral infections. The Company uses proprietary computer software and other technologies to develop its SMART[TM] humanized antibodies for potential use as effective pharmaceuticals without the limitations of traditional mouse-derived (murine) antibodies. PDL believes that its technologies are broadly applicable to a variety of diseases, as demonstrated by the Company's diverse product development pipeline and its collaborative, humanization and licensing arrangements with pharmaceutical and biotechnology companies. The Company has multiple product candidates in clinical development and numerous additional product candidates in preclinical studies. The Company's most advanced

product, Zenapax[R] (daclizumab), has been approved for marketing in the United States ("U.S."), Europe and several other countries for the prophylaxis of acute organ rejection in patients receiving renal transplantations. This product is exclusively licensed to Hoffmann-La Roche Inc. and its affiliates ("Roche") and in 1998 the Company began receiving royalties from sales of Zenapax.

Contact Details: 34801 Campus Drive Freemont CA 94555 United States of America Tel: 510 574 1400 Fax: Email: WWW: www.pdl.com/

Loading...

Recent Publications by Protein Design Labs Incorporated:
A semi-empirical mathematical model useful for describing the relationship between carbon dioxide, pH, lactate and base in a bicarbonate-buffered cell-culture process. The purpose of the present study was to develop a quantitative...	22nd August, 2007	Protein Design Labs, Inc., Brooklyn Park, MN 55445, USA.	Biotechnol Appl Biochem. 2007 Aug;47(Pt 4):197-204. DOI Direct Link
An engineered human IgG1 antibody with longer serum half-life. The serum half-life of IgG Abs is regulated by the neonatal Fc receptor...	17th February, 2006	Protein Design	J Immunol. 2006 Jan 1;176(1):346-56.
Design of humanized antibodies: from anti-Tac to Zenapax. Since the introduction of hybridoma technology, monoclonal antibodies have...	17th August, 2005	Protein Design Labs, Inc., 34801 Campus Drive, Fremont, CA 94555, USA.	Methods. 2005 May;36(1):69-83. DOI Direct Link
Training and feasibility protocols: acceptable under current laws and standards? Details missing. Since the introduction of hybridoma technology, monoclonal antibodies have...	3rd June, 2005	Protein Design Labs, Inc., Fremont, CA, USA.	Lab Anim (NY). 2005 Apr;34(4):23-4. DOI Direct Link
Humanization of a chicken anti-IL-12 monoclonal antibody. Chicken anti-IL-12 monoclonal antibodies were isolated by phage display...	23rd February, 2005	Protein Design Labs, Inc., 34801 Campus Drive, Fremont, CA 94555, USA.	J Immunol Methods. 2004 Dec;295(1-2):9-19. DOI Direct Link
→View more Protein Design Labs Incorporated research publications.

BioNews Results for Protein Design Labs Incorporated:
CytRx Fortifies Executive Suite with Addition of Chief Medical Officer	Pharmacy Choice:  Oct 22 2009 8:53PM Matching: protein design labs
CytRx Fortifies Executive Suite with Addition of Chief Medical Officer	Pharma Live:  Oct 16 2009 9:30AM Matching: protein design labs
CytRx Fortifies Executive Suite with Addition of Chief Medical Officer	SmartBrief:  Oct 14 2009 3:47AM Matching: protein design labs
CytRx Fortifies Executive Suite with Addition of Chief Medical Officer	Genetic Engineering News:  Oct 13 2009 1:42PM Matching: protein design labs
CytRx Fortifies Executive Suite with Addition of Chief Medical Officer	Yahoo! Canada:  Oct 13 2009 1:28PM Matching: protein design labs
Promote your company here: BioNewsCast - Press Release Distribution	→View more Protein Design Labs Incorporated news.

Protein Design Labs Incorporated Patents:
US Patent No.	Title
7022500	Humanized immunoglobulins
6013256	Method of preventing acute rejection following solid organ transplantation
5932448	Bispecific antibody heterodimers
5882644	Monoclonal antibodies specific for the platelet derived growth factor .beta. receptor and methods of use thereof
5834597	Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
→View more Protein Design Labs Incorporated patents.

Protein Design Labs Incorporated (PRW) Financial information Links from Barchart
PRW Quote from from Barchart.com
PRW Chart from from Barchart.com
PRW Profile from from Barchart.com
PRW Opinion from from Barchart.com
→View more Protein Design Labs Incorporated finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 16 individuals from Protein Design Labs Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 509 times since April 2007, the link to the organisation's website has been followed 101 times

Recent Search Terms used to find this page: protein design laboratory fremont CA | protein design laboratory fremont CA | zenapax sales in usa | protein development labs | protein design labs | protein design labs brooklyn park phone | fremont, ca protein design labs | what lsbd are used for protein | Protein design lab PDL | SMART technology Protein Design Laboratories Inc Fremont CA USA | .

Search for more companies in Freemont

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Protein Design Labs Incorporated